surgical robots

The US Food and Drug Administration has released draft guidance covering surgical robotics. The document, reported by MedTech Dive, outlines the agency's current thinking for developers and manufacturers of robotic surgical systems. Stakeholders in the medical device industry typically have the opportunity to comment on such drafts before final guidance is issued, which shapes approval expectations for robot-assisted surgery technologies.

A report covered by the Asahi Shimbun says women are selected less often than men to perform robot-assisted surgeries, pointing to a gender gap in access to this advanced surgical technology and training. The finding has drawn attention to inequality within surgical specialties as robotic systems become more common in operating rooms worldwide.

Medtronic, the global medical device maker, is investing in robotics and artificial intelligence for healthcare, raising questions among investors about the strategy behind the expansion. The move points to the company's push to grow beyond traditional devices into surgical robotics and AI-driven care, sectors where competitors are also racing to establish a lead.

The FDA has released new guidance establishing a common playbook for companies developing surgical robots. The framework is expected to give robotic surgery manufacturers a clearer, more consistent path through regulatory review. Industry watchers say it could lower barriers for new entrants and speed approval of next-generation surgical robotics systems across the market.